Tag: Ampersand Capital Partners
Ampersand acquires majority stake in in vitro diagnostics company ALPCO
Ampersand Capital Partners, a middle-market private equity firm, has acquired a majority stake in American Laboratory Products Company (ALPCO), an in vitro diagnostics company, for ... Read More
Thermo Fisher to acquire viral vector CDMO Brammer Bio for $1.7bn
Global life sciences company Thermo Fisher Scientific has agreed to acquire Massachusetts-based Brammer Bio from Ampersand Capital Partners for about $1.7 billion in cash. Brammer ... Read More